Literature DB >> 28083680

Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patients.

Torben Glatz1, Goran Marjanovic2, Birte Kulemann2, Olivia Sick2, Ulrich Theodor Hopt2, Jens Hoeppner2.   

Abstract

PURPOSE: In esophageal surgery, total minimally invasive techniques compete with hybrid and robot-assisted procedures. The benefit of the individual techniques for the patient remains vague. At our institution, the hybrid minimally invasive laparoscopic-thoracotomic esophagectomy (HMIE) has been routinely applied since 2013. We conducted this retrospective study to analyze the perioperative outcome.
METHODS: Since 2013, 60 patients were operated in HMIE technique for esophageal cancer. Each of these patients was paired according to the criteria of gender, BMI, age, tumor histology, pulmonary preexisting conditions, and a history of smoking with a patient treated by open esophagectomy (OE). Perioperative parameters were extracted from our prospectively maintained database and compared among the groups.
RESULTS: The HMIE and OE groups were homogeneous in terms of patient- and tumor-related data. There was no difference in lymph nodes harvested (22 vs. 20, p = 0.459) and R0-resection rate (95 vs. 93%, p = 0.500). The operation time for the HMIE was significantly shorter (329 vs. 407 min, p < 0.001). There was no difference between the groups with respect to surgical complications (37 vs. 37%, p = 0.575), but the patients undergoing hybrid technique showed more delayed gastric emptying (23 vs. 10%, p = 0.042). Pulmonary morbidity was significantly reduced after HMIE (20 vs. 42%, p = 0.009). This affected both the occurrence of pneumonia and pleural effusions. The difference in the overall complication rate was not significant (50 vs. 60%, p = 0.179), but life-threatening complications (Clavien/Dindo 4/5) were less frequent (2 vs. 12%, p = 0.031). Overall, there was significantly less need for transfusion after HMIE (18 vs. 50%, p < 0.001), and hospital (and IMC) stay was significantly shorter (14 (6) vs. 18 (7) days, p = 0.002 (0.003)). The multivariate analysis confirms the surgical procedure as an independent risk factor for the development of pulmonary complications (OR 3.2, p = 0.011). Furthermore, preexisting pulmonary conditions were identified as a risk factor (OR 3.6, p = 0.006).
CONCLUSION: Our retrospective analysis shows that reduction of postoperative pulmonary morbidity, perioperative blood loss, and shortening of hospital stay can be achieved by HMIE. The procedure is safe, and the rate of surgical complications and oncological radicality is comparable to the conventional procedure.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; Gastric pull-up; Minimally invasive surgery; Outcome; Postoperative morbidity

Mesh:

Year:  2017        PMID: 28083680     DOI: 10.1007/s00423-017-1550-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  25 in total

1.  Outcomes after minimally invasive esophagectomy: review of over 1000 patients.

Authors:  James D Luketich; Arjun Pennathur; Omar Awais; Ryan M Levy; Samuel Keeley; Manisha Shende; Neil A Christie; Benny Weksler; Rodney J Landreneau; Ghulam Abbas; Matthew J Schuchert; Katie S Nason
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

Review 2.  Comparison of outcomes between minimally invasive oesophagectomy and open oesophagectomy for oesophageal cancer.

Authors:  Wen-Ling Xiong; Rui Li; Hai-Ke Lei; Zheng-Ying Jiang
Journal:  ANZ J Surg       Date:  2015-10-19       Impact factor: 1.872

3.  International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG).

Authors:  Donald E Low; Derek Alderson; Ivan Cecconello; Andrew C Chang; Gail E Darling; Xavier Benoit DʼJourno; S Michael Griffin; Arnulf H Hölscher; Wayne L Hofstetter; Blair A Jobe; Yuko Kitagawa; John C Kucharczuk; Simon Ying Kit Law; Toni E Lerut; Nick Maynard; Manuel Pera; Jeffrey H Peters; C S Pramesh; John V Reynolds; B Mark Smithers; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

4.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

5.  Is there any benefit to incorporating a laparoscopic procedure into minimally invasive esophagectomy? The impact on perioperative results in patients with esophageal cancer.

Authors:  Jang-Ming Lee; Jen-Wei Cheng; Ming-Tsang Lin; Pei-Ming Huang; Jin-Shing Chen; Yung-Chie Lee
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

6.  A standardized anesthetic and surgical clinical pathway for esophageal resection: impact on length of stay and major outcomes.

Authors:  Grete H Porteous; Joseph M Neal; April Slee; Henner Schmidt; Donald E Low
Journal:  Reg Anesth Pain Med       Date:  2015 Mar-Apr       Impact factor: 6.288

7.  Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.

Authors:  S Lorenzen; M Hentrich; C Haberl; V Heinemann; T Schuster; T Seroneit; N Roethling; C Peschel; F Lordick
Journal:  Ann Oncol       Date:  2007-07-28       Impact factor: 32.976

8.  [Hybrid laparoscopic thoracotomic esophagectomy with intrathoracic esophagogastric anastomosis].

Authors:  J Hoeppner; G Marjanovic; T Glatz; B Kulemann; U T Hopt
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

9.  Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.

Authors:  Jens Hoeppner; Katja Zirlik; Thomas Brunner; Peter Bronsert; Birte Kulemann; Olivia Sick; Goran Marjanovic; Ulrich Theodor Hopt; Frank Makowiec
Journal:  J Surg Oncol       Date:  2013-11-26       Impact factor: 3.454

10.  Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial.

Authors:  K W Maas; M A Cuesta; M I van Berge Henegouwen; J Roig; L Bonavina; C Rosman; S S Gisbertz; S S A Y Biere; D L van der Peet; J H Klinkenbijl; M W Hollmann; E S de Lange; H J Bonjer
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

View more
  9 in total

Review 1.  Is There a Rationale for Structural Quality Assurance in Esophageal Surgery?

Authors:  Torben Glatz; Jens Höppner
Journal:  Visc Med       Date:  2017-03-24

Review 2.  Upper Gastrointestinal Surgery: Robotic Surgery versus Laparoscopic Procedures for Esophageal Malignancy.

Authors:  Matthias Biebl; Andreas Andreou; Sascha Chopra; Christian Denecke; Johann Pratschke
Journal:  Visc Med       Date:  2018-02-16

3.  Clinical outcomes of video-assisted thoracoscopic surgery esophagectomy for esophageal cancer: a propensity score-matched analysis.

Authors:  Duk Hwan Moon; Jong Mog Lee; Jae Hyun Jeon; Hee Chul Yang; Moon Soo Kim
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Postoperative short-term outcomes of minimally invasive versus open esophagectomy for patients with esophageal cancer: An updated systematic review and meta-analysis.

Authors:  Naeem M Akhtar; Donglai Chen; Yuhuan Zhao; David Dane; Yuhang Xue; Wenjia Wang; Jiaheng Zhang; Yonghua Sang; Chang Chen; Yongbing Chen
Journal:  Thorac Cancer       Date:  2020-04-20       Impact factor: 3.500

5.  A refined procedure for esophageal resection using a full minimally invasive approach.

Authors:  Simon K Ashiku; Ashish R Patel; Brandon H Horton; Jeffrey Velotta; Sora Ely; Andrew L Avins
Journal:  J Cardiothorac Surg       Date:  2022-03-04       Impact factor: 1.637

6.  Perioperative statin medication impairs pulmonary outcome after abdomino-thoracic esophagectomy.

Authors:  Martin Reichert; Maike Lang; Joern Pons-Kühnemann; Michael Sander; Winfried Padberg; Andreas Hecker
Journal:  Perioper Med (Lond)       Date:  2022-09-14

7.  C-Reactive Protein as Predictor for Infectious Complications after Robotic and Open Esophagectomies.

Authors:  Florian Richter; Anne-Sophie Mehdorn; Thorben Fedders; Benedikt Reichert; Jan-Hendrik Egberts; Thomas Becker; Julius Pochhammer
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

8.  Efficacy of hybrid minimally invasive esophagectomy vs open esophagectomy for esophageal cancer: A meta-analysis.

Authors:  Jiao Yang; Ling Chen; Ke Ge; Jian-Le Yang
Journal:  World J Gastrointest Oncol       Date:  2019-11-15

Review 9.  Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta-analysis.

Authors:  K Siaw-Acheampong; S K Kamarajah; R Gujjuri; J R Bundred; P Singh; E A Griffiths
Journal:  BJS Open       Date:  2020-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.